DaVita Inc.
NYSE:DVAMedical - Care Facilities
+$1.60 today
- Market cap
- $10.18B
- Beta
- 0.91
- P/E (TTM)
- 18.2
- EPS (TTM)
- $11.60
Volume 1.12M
Average 0.84M
DVA Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
DaVita Inc.NYSE: DVA
Operating Margin · Q2 FY2026 · quarter ended Jun 2026
Operating margin holds steady near 16.1%
Operating margin was 16.1% in Q2 FY2026, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 15.1%, down 0.7 pp year over year. Over 3 fiscal years it widened by 3.2 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 5 analysts of 13.4% for the fiscal year ending Dec 2026, down from 14.7% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 16.1%+2.0 pp QoQ
- Last fiscal yearDec 2025
- 14.7%-1.6 pp YoY
- LTMJun 2026
- 15.1%-0.7 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.1 pp | -2.1 pp | -2.2 pp |
| 1 year | -1.6 pp | -1.4 pp | +0.2 pp |
| 3 years | +3.2 pp | +0.7 pp | -2.5 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 14.7%
- Year-over-year change
- -1.6pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.7% | -1.6pp |
| FY2024 | 2024-12-31 | 16.3% | +3.1pp |
| FY2023 | 2023-12-31 | 13.2% | +1.7pp |
| FY2022 | 2022-12-31 | 11.5% | -3.9pp |
| FY2021 | 2021-12-31 | 15.5% | — |
Operating Margin vs competitors
How DVA compares with its peers on the latest reported figures
- DVA's LTM Jun 2026 operating margin of 15.1% is the highest of the 3 companies compared; the peer median is 3.7%.
- Its year-over-year change of -0.7 pp is the 2nd highest of 3, against a peer median of -0.4 pp.
- Over three fiscal years its change of +3.2 pp compares with a peer median of +13.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 15.1% | -0.7 pp | +3.2 pp | |
| LTM Jun 2026 | 9.7% | +1.3 pp | +1.5 pp | |
| LTM Jun 2026 | -2.4% | -2.1 pp | +25.5 pp | |
| Peer median (excluding DVA) | 3.7% | -0.4 pp | +13.5 pp | |
Competitors are the stored peer set for DVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11.62B | 11.61B | 12.14B | 12.82B | 13.64B |
| Cost of Revenue | 7.97B | 8.21B | 8.32B | 8.6B | 9.96B |
| Gross Profit | 3.65B | 3.4B | 3.82B | 4.22B | 3.68B |
| Gross Margin | 31.4% | 29.3% | 31.5% | 32.9% | 27.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.2B | 1.36B | 1.47B | 1.54B | 1.67B |
| Operating Expenses | 1.85B | 2.06B | 2.22B | 2.13B | 1.67B |
| Depreciation & Amortization | 680.62M | 732.6M | 745.44M | 723.86M | 715.35M |
| EBITDA | 2.48B | 2.06B | 2.32B | 2.72B | 2.64B |
| EBITDA Margin | 21.4% | 17.7% | 19.1% | 21.3% | 19.4% |
| Operating Income | 1.8B | 1.34B | 1.6B | 2.09B | 2.01B |
| Operating Margin | 15.5% | 11.5% | 13.2% | 16.3% | 14.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 285.25M | 357.02M | 398.55M | 470.47M | 549.67M |
| Other Income / Expenses | (278.88M) | (372.78M) | (425.69M) | (560.09M) | (663.79M) |
| Income Before Tax | 1.52B | 966.28M | 1.18B | 1.53B | 1.35B |
| Pre-Tax Margin | 13.1% | 8.3% | 9.7% | 11.9% | 9.9% |
| Income Tax Expense | 306.73M | 198.09M | 220.12M | 279.66M | 293.11M |
| Net Income | 978.45M | 560.4M | 691.54M | 936.34M | 746.8M |
| Net Margin | 8.4% | 4.8% | 5.7% | 7.3% | 5.5% |
| EPS (Basic) | 9.30 | 5.88 | 7.62 | 11.02 | 9.72 |
| EPS (Diluted) | 8.90 | 5.71 | 7.42 | 10.73 | 9.51 |
| Weighted Avg Shares | 105.23M | 92.99M | 90.79M | 84.99M | 86.1M |
| Weighted Avg Shares (Diluted) | 109.95M | 95.83M | 93.18M | 87.27M | 88.1M |
DaVita Inc.
NYSE:DVA
Intrinsic Alpha fair value
Locked
Current Price
$161.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.